packageBenralizumab

benralizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Benralizumab is a monoclonal antibody used as an antiasthmatic drug for obstructive airway disease, and has also been studied for chronic spontaneous urticaria. It is authorised in the European Union for asthma and is also under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q3638304 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:benralizumab
ATC codes:R03DX10
DrugBank:DB12023
Wikidata:Q3638304
molar mass:146054 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown